Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effective Dose of Alfentanil Combined with Propofol for LMA Insertion in Children
ChiCTR2600124927Phase 4Not yet recruiting
- Sponsor
- Zhongshan Ophthalmic Center
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of alfentanil, sponsored by Zhongshan Ophthalmic Center. Primary endpoints: Success of LMA insertion and ED50 and ED95 of alfentanil combined with propofol for LMA insertion. Planned start May 2026; status: not yet recruiting.
02
Drugs
alfentanil
Beyond the preview
Go deeper on ChiCTR2600124927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600124927.